Search for: "Lisa Ouellette"
Results 121 - 140
of 173
Sorted by Relevance
|
Sort by Date
30 Oct 2020, 12:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
27 Aug 2021, 12:18 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
12 Oct 2020, 11:52 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsA recent STAT News report found that Operation Warp Speed—the government’s Manhattan Project-style effort to quickly develop a COVID-19 vaccine—has substantial military involvement. [read post]
24 Jan 2017, 12:06 pm
Rev. 1525 ] appeared in IPBizSeparately, some commentary from Lisa Larrimore Ouellette related to Lemley's Myth of the Solo Inventor, and "review" of law review articles:Lemley isn't making any claims about the scope of the patents these inventors received, so whether "bamboo" appears in Edison's patent is irrelevant. [read post]
18 Feb 2021, 10:24 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn our last post, we introduced some of the clinical evidence supporting the use of therapeutic antibodies against COVID-19—including Regeneron’s casirivimab and imdevimab and Eli Lilly’s bamlanivimab—and analyzed the existing problems in the distribution and administration of those therapies. [read post]
30 Jul 2020, 3:39 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
22 Mar 2017, 4:42 am
” In a Wall Street Journal op-ed, Daniel Hamel and Lisa Larrimore Ouellette maintain that the case is essentially “about price discrimination, the practice of charging higher prices to customers who likely can pay more and offering discounts to those who cannot,” and they urge the justices to “consider what their decision might mean for consumers beyond the U.S. [read post]
25 Mar 2013, 11:23 am
More from Lyle Denniston and Lisa Larrimore Ouellette. [read post]
21 Jan 2015, 2:46 am
Commentary comes from Lisa Larrimore Ouellette at Written Description. [read post]
1 Feb 2022, 6:48 am
Durvasula, Lisa Larrimore Ouellette, and Heidi L. [read post]
27 Mar 2017, 4:18 am
At Written Description, Lisa Ouellette offers some “thoughts on the policy tradeoffs” at play in Impression Products, Inc. v. [read post]
1 May 2018, 4:37 am
Lisa Ouellette has astutely observed that the importance of agency-head final decision-making authority merits further theoretical development and empirical investigation. [read post]
9 Sep 2012, 4:24 pm
Sawicki, Assistant Professor, Loyola Chicago School of Law; 2003-2009, George Sharswood Fellow in Law and Bioethics, University of Pennsylvania Law School Lisa Comeau, Esq., appellate counsel for the patient’s family in Cronin v. [read post]
6 Feb 2015, 6:00 am
Lisa Larrimore Ouellette (Stanford) (@PatentScholar) has created a Twitter list that makes it easier to follow all of the professors listed in the census. [read post]
6 Jan 2015, 6:46 pm
Thomas Anthony Niedwiecki LawProfAnt John Marshall (Chicago) Sean Nolon snolon Vermont Tracy Norton millennialprof Touro Tracy Norton profnorton Touro Beth Simone Noveck bethnoveck NYLS Rory O'Connell rjjoconnell Queens University Belfast Shuyi Oei ShuyiOei Tulane Paul Ohm paulohm Colorado David Opderbeck dopderbeck Seton Hall Lisa Ouellette PatentScholar Stanford Kevin Outterson koutterson Boston University Jessica Owley JessicaOwley Buffalo Frank Pasquale FrankPasquale Seton… [read post]
20 May 2020, 1:58 pm
Guest Post by Colleen V. [read post]
2 Oct 2020, 7:10 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn recent weeks, a number of articles have reported great concern around the politicization of the approval process for future COVID-19 vaccines. [read post]
25 Mar 2021, 1:24 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
9 Mar 2018, 12:54 pm
To give one example, in their recent article, Bayh-Dole Without Borders, Lisa Larrimore Ouellette and Daniel Hemel observe that an under-appreciated feature of making federal funding for research work as an economic policy is ensuring that U.S. companies are able to protect the results of that federally-funded research abroad. [read post]
